5
3
3
↑5
↓3
—3
Evidence suggests Calcium mayincreaseCalcium balance.
7 studies (11 claims)
Conflicting evidence
Typical effective dose 1250 (1125–1375) mgacross 2 dosed studies
Study Claims
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| blood concentrations of calcium | No effect - may reflect a disturbed calcium phosphate balance | calcium phosphate balance | Human | — | Not specified | The role of calcium in the prevention of cardiovascular disease--a review of observational studies and randomized clinical trials.cited 33× |
| calcium supplementation | No effect - effect | calcium and bone metabolism, and bone mineral balance | Human | women | 1000 mg calcium supplement (single dose before exercise). | The effect of calcium supplementation on calcium and bone metabolism during load carriage in women: protocol for a randomised controlled crossover trial. |
| calcium-free fluid with magnesium concentration of 1.50 mmol/l | No effect - provided even balances | median balance of Mg | Human | patients on CRRT with RCA modality | 1.50 mmol/l magnesium in calcium-free fluid. | The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.cited 11× |
| calcium-free fluid with magnesium concentration of 1.50 mmol/l | Increases - resulted in | median balance of Mg | Human | patients on CRRT with RCA modality | 1.50 mmol/l magnesium in calcium-free fluid. | The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.cited 11× |
| calcium-free fluid with magnesium concentration of 1.50 mmol/l at 3,000 ml/h | Increases - increased | median balance of Mg | Human | patients on CRRT with RCA modality | 1.50 mmol/l magnesium in calcium-free fluid. | The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.cited 11× |
| calcium-free fluid with magnesium concentration of 0.75 mmol/l with additional magnesium substitution | Decreases - resulted in | median balance of Mg | Human | patients on CRRT with RCA modality | 1.50 mmol/l magnesium in calcium-free fluid. | The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.cited 11× |
| calcium-free fluid with magnesium concentration of 1.50 mmol/l with higher blood flow and dosage of citrate | No effect - resulted in | median balance of Mg | Human | patients on CRRT with RCA modality | 1.50 mmol/l magnesium in calcium-free fluid. | The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.cited 11× |
| elementary calcium 500 mg/day and cholecalciferol 1,000 IU/day | Increases - significantly improved | static balance (UST) | Human | postmenopausal women | Aquatic exercise program (HydrOS) for 24 weeks; calcium 500 mg/day and cholecalciferol 1,000 IU/day for both groups. | High-intensity aquatic exercises (HydrOS) improve physical function and reduce falls among postmenopausal women.cited 26× |
| citrate anticoagulation with calcium replacement | Decreases - patients experienced a mean calcium loss of | calcium balance | Human | intensive care patients requiring CVVHD-F | Predilution Prismocitrate 10/2 flows of 1660 mL/h (delivering 2.42 mmol citrate per litre of blood) for citrate; Hemosol B0 predilution flows of 2058 mL/h for heparin. | Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation.cited 24× |
| calcium supplementation based on plasma ionized calcium levels | Decreases - was negative | calcium balance | Human | most patients during citrate CVVH | Not specified | Negative calcium balance despite normal plasma ionized calcium concentrations during citrate anticoagulated continuous venovenous hemofiltration (CVVH) in ICU patients.cited 1× |
| calcium carbonate supplement (1500 mg/day calcium) | Increases - produced positive calcium balance | calcium balance | Human | patients with stage 3 or 4 CKD | 1500 mg/day calcium (as calcium carbonate). | Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.cited 174× |
| calcium carbonate supplement (1500 mg/day calcium) | Increases - demonstrated positive net bone balance | net bone balance | Human | patients with stage 3 or 4 CKD | 1500 mg/day calcium (as calcium carbonate). | Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.cited 174× |
| calcium carbonate supplement (1500 mg/day calcium) | No effect - did not affect phosphorus balance | phosphorus balance | Human | patients with stage 3 or 4 CKD | 1500 mg/day calcium (as calcium carbonate). | Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.cited 174× |